NEW YORK (GenomeWeb News) — A network of 37 genomics research groups from 13 European countries has adopted an agenda for pathogenomics research that includes increasing emphasis on pathogen/host interaction and on using bioinformatics technologies, according to the alliance.
The Network of Excellence EuroPathoGenomics is a five-year, €6.7-million ($9 million) European Commission initiative begun in 2005. The group met in April to outline a new direction for its programs and to discuss the future of genomics research in Europe.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.